Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPTLC2 | O15270 | 4/20 | 0.76 |
| ▸ | BRD4 | O60885 | 1/20 | 0.53 |
| ▸ | BRD2 | P25440 | 1/20 | 0.53 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.53 |
| ▸ | SPTLC3 | Q9NUV7 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.48 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6981749 | 0.94 | SPTLC2 (0.85) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6981735 | 0.93 | SPTLC2 (0.89) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6968663 | 0.90 | SPTLC2 (0.84) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6979289 | 0.89 | SPTLC2 (0.71) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6970294 | 0.89 | SPTLC2 (0.66) | SPTLC2SPTLC3PDE4APDE4BPDE4C | |
| SCHEMBL6981585 | 0.88 | SPTLC2 (0.75) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6975238 | 0.87 | SPTLC2 (1.00) | SPTLC2SPTLC3PDE4APDE4BPDE4C | |
| SCHEMBL6979836 | 0.83 | SPTLC2 (0.70) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6977888 | 0.82 | SPTLC2 (0.69) | SPTLC2BRD4BRD2BRD3SPTLC3 | |
| SCHEMBL6971216 | 0.82 | SPTLC2 (0.63) | SPTLC2SPTLC3PDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216398-A1 | Soluble beta amyloid precursor protein secretion promoters | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1283055-A1 | SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS | Takeda Chemical Industries, Ltd. (JP) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216398-A1 | Soluble beta amyloid precursor protein secretion promoters | APP, BDNF, BACE1 | SPTLC2 3161/4885BRD4 4025/4885BRD2 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.